[1]唐金蓉,张 碟,李 盛.四种中药单体联合亚胺培南对耐碳青霉烯肺炎克雷伯菌体外抑菌作用研究[J].现代检验医学杂志,2022,37(06):162-165+197.[doi:10.3969/j.issn.1671-7414.2022.06.031]
 TANG Jin-rong,ZHANG Die,LI Sheng.Antibacterial Activity of Four Traditional Chinese Medicine Momonomers Combined with Imipenem Against Carbapenem-resistant Klebsiella Pneumoniae in Vitro[J].Journal of Modern Laboratory Medicine,2022,37(06):162-165+197.[doi:10.3969/j.issn.1671-7414.2022.06.031]
点击复制

四种中药单体联合亚胺培南对耐碳青霉烯肺炎克雷伯菌体外抑菌作用研究()
分享到:

《现代检验医学杂志》[ISSN:/CN:]

卷:
第37卷
期数:
2022年06期
页码:
162-165+197
栏目:
研究简报·实验技术
出版日期:
2022-11-15

文章信息/Info

Title:
Antibacterial Activity of Four Traditional Chinese Medicine Momonomers Combined with Imipenem Against Carbapenem-resistant Klebsiella Pneumoniae in Vitro
文章编号:
1671-7414(2022)06-162-05
作者:
唐金蓉张 碟李 盛
(成都中医药大学附属绵阳医院检验科,四川绵阳 621000)
Author(s):
TANG Jin-rongZHANG DieLI Sheng
(Department of Clinical Laboratory,Mianyang Hospital Affililiated to Chengdu University of Traditional Chinese Medicine,Sichuan Mianyang 621000,China)
关键词:
中药单体亚胺培南耐碳青霉烯肺炎克雷伯菌最低抑菌浓度
分类号:
R378.996;R446.5
DOI:
10.3969/j.issn.1671-7414.2022.06.031
文献标志码:
A
摘要:
目的 研究小檗碱、穿心莲内酯、黄芩苷和栀子苷四种中药单体分别联合亚胺培南(imipenem,IMP)对耐碳青霉烯肺炎克雷伯菌 (carbapenem-resistant Klebsiella pneumoniae, CRKP) 的体外抑菌作用。方法 选取成都中医药大学附属绵阳医院2021 年1 ~ 6 月从临床标本中分离出的6 株非重复CRKP 菌株,微量肉汤稀释法测定四种中药单体分别对6 株CRKP 的最低抑菌浓度(minimum inhibitory concentration, MIC),棋盘法测定中药单体分别联合IMP 对CRKP 的MIC, 计算部分抑菌浓度指数(FIC)。采用两独立样本的Wilcoxon 秩和检验比较各组药物联合前后MIC 的变化 。结果 小檗碱、穿心莲内酯、黄芩苷和栀子苷对CRKP 的MIC 分别为2 500μg/ml,2 500μg/ml,5 000 ~ 10 000μg/ml和> 10 000μg/ml。黄芩苷联合IMP 对6 株CRKP 的FIC 为0.375 ~ 0.75,出现协同作用(3 株),小檗碱、穿心莲内酯和栀子苷联合IMP 对CRKP 的FIC 为0.625 ~ 1.25, 未出现协同作用。黄芩苷联合IMP 后可降低IMP 的MIC,差异有统计学意义(Z=-2.459,P < 0.05)。小檗碱、穿心莲内酯和栀子苷联合IMP 后IMP 的MIC 变化差异无统计学意义(Z=-1.950 ~ 0.000,均P > 0.05)。结论 黄芩苷同IMP 联合对CRKP 具有协同作用,同时能降低CRKP 对IMP 的耐药性。
Abstract:
Objective To explore the antibacterial activity of berberine, andrographolide, baicalin, and geniposide combined with imipenem (IMP) against carbapenem-resistant Klebsiella pneumoniae (CRKP) in vitro. Methods Six non-repeating CRKP strains isolated from clinical specimens from January to June 2021 at Mianyang Hospital Affiliated to Chengdu University of Traditional Chinese Medicine were selected.A broth microdilution method was used to determine the minimum inhibitory concentration (MIC) of four Traditional Chinese medicine monomers against six strains of CRKP. MICs of each of the four Traditional Chinese medicine monomers combined with IMP were determined using the checkerboard method against CRKP. The fractional inhibitory concentration (FIC) index was calculated. wilcoxon rank sumtest of two independent samples was used to compare the changes of MIC before and after drug combination in each group. Results Bernerine, andrographolide, baicalin, and geniposide had MICs of 2 500μg/ml, 2 500μg/ml, 5 000 ~ 10 000μg/ml, and more than 10 000μg/ml to CRKP, respectively. It was found that baicalin and IMP had FICs that ranged from 0.375 to 0.75 against CRKP, with synergy(3 strains). Berberine, andrographolide, geniposide, and IMP had FICs ranging from 0.625 ~ 1.25, without synergy. The combination of baicalin and IMP reduced the MIC value of IMP, and the difference was statistically significant (Z=-2.459, P<0.05). In the combination of berberine, andrographolide, and geniposide with IMP, there was no difference in the MIC value for IMP (Z=-1.950 ~ 0.000, all P > 0.05). Conclusion In combination with IMP, baicalin has synergistic effects on CRKP and can reduce the resistance of CRKP to IMP.

参考文献/References:

[1] 全国细菌耐药监测网 .全国细菌耐药监测网 2014~ 2019年耐碳青霉烯类肺炎克雷伯菌流行病学变迁 [J].中国感染控制杂志 ,2021,20(2):175-179. China Antimicrobial Resistance Surveillance System. Epidemiological change in carbapenem-resistant Klebsiella pneumoniae:surveillance report from China Antimicrobial Resistance Surveillance in 2014~ 2019 [J]. Chinese Journal of Infection Control,2021,20(2):175-179.
[2] AGYEMAN A A, BERGEN P J, RAO G G, et al. A systematic review and meta-analysis of treatment outcomes following antibiotic therapy among patients with carbapenem-resistant Klebsiella pneumoniae infections[J]. International Journal of Antimicrobial Agents, 2020, 55(1): 105833.
[3] 徐卫皓 , 杨凤真 , 伊茂礼 , 等.临床耐碳青霉烯类肠杆菌科细菌对头孢他啶 /阿维巴坦的药物敏感性分析 [J].现代检验医学杂志 , 2022, 37(1):164-167. XU Weihao, YANG Fengzhen, YI Maoli , et al. Drug sensitivity analysis of clinical Carbapenem-resistant Enterobacteriaceae bacteria to Ceftazidime/ Avibatan [J]. Journal of Modern Laboratory Medicine, 2022,37(1):164-167.
[4] 程成 , 张薇 , 朱波 , 等 .中药抗常见耐药菌的作用及其机制研究进展 [J].南京中医药大学学报 , 2019, 35(2):229-233. CHENG Cheng, ZHANG Wei, ZHU Bo, et al. Effects and mechanisms of traditional chinese medicine on drug-resistant bacteria: research progress and future directions [J].Journal of Nanjing University of Traditional Chinese Medicine, 2019,35(2):229-233.
[5] 马冬梅 , 陶庆春 , 齐宏伟.痰热清联合亚胺培南或米诺环素对广泛耐药肺炎克雷伯菌的体外抑菌作用 [J].中国临床研究 , 2019, 32(4):549-551. MA Dongmei, TAO Qingchun, QI Hongwei. Inhibitory effect of Tanreqing combined with imipenem or minocycline on extensively drug-resistant Klebsiella pneumoniae in vitro [J]. Chinese Journal of Clinical Research,2019,32(4):549-551.
[6] 杜蕾 ,焦伟杰 ,张翔云等 .清金化痰汤联合亚胺培南体外抑菌活性研究 [J].中西医结合研究 , 2022, 14(2):93-96. DU Lei, JIAO Weijie, ZHANG Xiangyun, et al. In vitro antibacterial activity study of Qingjin Huatan decoction combined with imipenem for multidrug resistant Klebsiella pneumoniae [J]. Research of Integrated Traditional Chinese and Western Medicine, 2022, 14(2):93-96.
[7] Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing.Thirty informational supplement[S].Wayne: PA, CLSI M100-S30, 2020.
[8] XU Liangfei, SUN Xiaoxi, MA Xiaoling.Systematic review and meta-analysis of mortality of patients infected with carbapenem-resistant Klebsiella pneumoniae[J]. Annals of Clinical Microbiology and Antimicrobials, 2017, 16(1): 18.
[9] 杜芳玲 , 梅艳芳 , 魏丹丹 , 等.CRKP血流感染危险因素和耐药及毒力特征 [J].中华医院感染学杂志 , 2021, 31(22):3361-3365. DU Fangling, MEI Yanfang, WEI Dandan, et al. Risk factors for CRKP bloodstream infection, drug resistance and virulence characteristics [J]. Chinese Journal of No socomiology,2021,31(22):3361-3365.
[10] MIETHKE M, PIERONI M, WEBER T, et al. Towards the sustainable discovery and development of new antibiotics[J]. Nature Reviews Chemistry, 2021, 5(10): 726-749.
[11] 黄梅 , 谭余庆 , 罗俊 , 等 .植物类中药抗细菌耐药性的研究进展 [J].中国实验方剂学杂志 , 2018, 24 (23): 218-224. HUANG Mei, TAN Yuqing, LUO Jun, et al. Antimicro-bial resistance of chinese herbal medicine [J]. Chinese Journal of Experimental Traditional Medical Formulae, 2018, 24 (23):218-224.
[12] 翟贯星 ,陆璐 ,陈代杰 ,等 .中药化合物的抗菌及增效作用 [J].中国抗生素杂志 , 2019,44(12):1366-1370. ZHAI Guanxing, LU Lu, CHEN Daijie,et al. Antimicrobial and synergisicm effects of traditional Chinese medicine compounds [J]. Chinese Journal of Antibiotics,2019,44(12):1366-1370.
[13] 干铁儿 ,林少华 ,李文杰 ,等 .黄连素联合亚胺培南西司他丁对耐碳青霉烯类肺炎克雷伯菌的体外抑菌作用 [J].中华医院感染学杂志 , 2021, 31(21): 3211-3215. GAN Tie’er, LIN Shaohua, LI Wenjie, et al. In vitro antibacterial effect of berberine combined with imipenem-cilastatin on carbapenem-resistant Klebsiella pneumoniae [J]. Chinese Journal of Nosocomiology, 2021,31(21):3211-3215.
[14] 吴缠婷 , 周良良 , 邹婉清 , 等 .黄芩苷的药理特性及其作用机制研究进展 [J].中华中医药学刊 , 2022, 40(2):63-67. WU Chanting, ZHOU Liangliang, ZOU Wanqing, et al. Research progress on pharmacological properties and mechanism of Baicalin [J]. Chinese Archives of Traditional Chinese Medicine,2022,40(2):63-67.
[15] 陈朝彦 , 秦志丹 , 蒋良艳 , 等.双组分系统调控肺炎克雷伯菌碳青霉烯耐药机制的研究进展 [J].中华危重病急救医学 , 2021, 33(6):761-764. CHEN Chaoyan, QIN Zhidan, JIANG Liangyan, et al. Research progress on the mechanism of two-component systems in regulating carbapenem resistance of Klebsiella pneumonia [J]. Chinese Critical Care Medicine, 2021,33(6):761-764.
[16] 韩佳慧 , 刘唐娟 , 罗劲 , 等 .不同浓度黄芩苷对高毒力肺炎克雷伯菌生长及生物被膜形成能力影响的初步探讨 [J].临床肺科杂志 , 2022, 27(3):342-345. HAN Jiahui, LIU Tangjuan, LUO Jin, et al. A preliminary study on the effects of different concentrations of Baicalin on the growth and biofilm formation of hypervirulent Klebsiella pneumoniae [J]. Journal of Clinical Pulmonary Medicine,2022,27(3):342-345.
[17] SHI Cheng, BAO Jingxiao, SUN Ying, et al. Discovery of Baicalin as NDM-1 inhibitor: Virtual screening, biological evaluation and molecular simulation [J]. Bioorganic Chemistry, 2019, 88: 102953.
[18] 高元峰 , 王瑞颖 , 易柳 , 等.中国药典 2020年版 (一部 )收载毒性中药及其注意事项统计分析 [J].中国药师 , 2021, 24(6):1133-1137. GAO Yuanfeng, WANG Ruiying, YI Liu, et al. Statistical analysis of toxic herbs and points for attention in Chinese pharmacopoeia(2020 Edition,Part I)[J]. China Pharmacist,2021,24(6):1133-1137.

相似文献/References:

[1]李晓晴,惠海英,骆志成.香叶醇、β-香茅醇和丁香酚抗念珠菌活性的体外研究[J].现代检验医学杂志,2016,31(02):87.[doi:10.3969/j.issn.1671-7414.2016.02.026]
 LI Xiao-qing,HUI Hai-ying,LUO Zhi-cheng.Study on Anticandidal Activities of Geraniol, β-Citronellol and Eugenol in Vitro[J].Journal of Modern Laboratory Medicine,2016,31(06):87.[doi:10.3969/j.issn.1671-7414.2016.02.026]
[2]黄秋兰,钱巧慧,范德平,等.鱼腥草联合亚胺培南对碳青霉烯耐药铜绿假单胞菌杀菌效果的体外研究[J].现代检验医学杂志,2021,36(03):118.[doi:10.3969/j.issn.1671-7414.2021.03.027]
 HUANG Qiu-lana,QIAN Qiao-hui,FAN De-pinga,et al.Vitro Study on the Bactericidal Effect of Houttuynia Cordata Combined withImipenem Against Carbapenem Resistant Pseudomonas Aeruginosa[J].Journal of Modern Laboratory Medicine,2021,36(06):118.[doi:10.3969/j.issn.1671-7414.2021.03.027]

备注/Memo

备注/Memo:
基金项目:绵阳市卫健委补助项目(202110);四川中医药文化传承与研究中心规划项目(2020Y003)。
作者介绍:唐金蓉(1986-),女,本科,主管检验师,主要研究方向:微生物检验,E-mail:236598569@qq.com。
通讯作者:李 盛(1976-),男,本科,副主任技师,E-mail:458714021@qq.com。
更新日期/Last Update: 2022-11-15